A new study led by University of Toronto researchers has shown that immune cells in the gut follow an atypical pathway to ...
As the days continue to get shorter, scientists have made a significant discovery in understanding exactly what makes mammals ...
The field of tissue-immune interactions has undergone significant transformation as emerging evidence demonstrates the centrality of local microenvironments ...
Invisible, toxic fungi in animal feed can slash livestock productivity, weaken immunity, and pose serious health risks to ...
A new phase 1 randomized controlled trial finds that a single dose of the ChAdox1 Rift Valley fever (RVF) vaccine appears ...
Data presented at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting The spliceosome targeting payload, PH1, ...
In preclinical experiments, the combination of Trastuzumab PH1 + anti-PD1 outperforms the combination of Kadcyla® + anti-PD1 with a statistically significantly greater rate of Complete Responses (74% ...
Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, ...
Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...
A Lassa fever vaccine candidate was safe and produced a strong immune response in adults in the United States and Liberia, ...
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and Liberia Key takeaways: IAVI's ...
Findings are consistent with previous studies of a similarly constructed licensed Ebolavirus vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback